france reimbursment

Vertex Announces Agreement with French Authorities for National Reimbursement of a Cystic Fibrosis Medicine

CRISP Announcement Image November 19

With our partner CRISPR Tx, we announced positive efficacy data from the first two patients treated with CTX001, our CRISPR/Cas9 gene-editing therapy for beta thalassemia and sickle cell disease

Triple Announcement

U.S. FDA Approves Our Fourth CF Medicine

Biotechnology to Create Transformative Medicines

At Vertex, we're relentless in our pursuit of medical research to create transformative medicines for people with serious and life-threatening diseases, like cystic fibrosis.

pipeline and medicine

Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

working here

At Vertex, we have some of the industry's best and brightest people helping us achieve our mission of discovering transformative medicines to help people with serious diseases, like cystic fibrosis. 


U.S. FDA Approves Our Fourth CF Medicine

Follow Us for Updates